{"transactions":[{"id":4250703,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":174218,"kind":"person","name":"Vandervelpen Nico","position":1,"cik":"0001618165","reported_name":"Vandervelpen Nico","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-07-26T21:03:10.000Z","date":"2017-07-24","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on June 1, 2017 and provides for vesting in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 1, 2017 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on June 1, 2017 and provides for vesting in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 1, 2017 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date."}],"balance_after":12500,"derivative":{"exercise_price":10,"expiration_date":"2018-07-24","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-17-046339","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919117046339/doc4.xml","form_type":"4"}},{"id":4250702,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":174218,"kind":"person","name":"Vandervelpen Nico","position":1,"cik":"0001618165","reported_name":"Vandervelpen Nico","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-07-26T21:03:10.000Z","date":"2017-07-24","kind":"disposition_to_issuer","acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on June 1, 2017 and provides for vesting in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 1, 2017 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on June 1, 2017 and provides for vesting in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 1, 2017 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date."}],"balance_after":0,"derivative":{"exercise_price":10,"expiration_date":"2027-05-31","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-17-046339","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919117046339/doc4.xml","form_type":"4"}},{"id":4250701,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":174218,"kind":"person","name":"Vandervelpen Nico","position":1,"cik":"0001618165","reported_name":"Vandervelpen Nico","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-07-26T21:03:10.000Z","date":"2017-07-24","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on June 16, 2016 and provides for vesting in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 16, 2016 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on June 16, 2016 and provides for vesting in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 16, 2016 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date."}],"balance_after":12500,"derivative":{"exercise_price":10.2,"expiration_date":"2018-07-24","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-17-046339","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919117046339/doc4.xml","form_type":"4"}},{"id":4250700,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":174218,"kind":"person","name":"Vandervelpen Nico","position":1,"cik":"0001618165","reported_name":"Vandervelpen Nico","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-07-26T21:03:10.000Z","date":"2017-07-24","kind":"disposition_to_issuer","acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on June 16, 2016 and provides for vesting in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 16, 2016 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on June 16, 2016 and provides for vesting in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 16, 2016 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date."}],"balance_after":0,"derivative":{"exercise_price":10.2,"expiration_date":"2026-06-15","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-17-046339","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919117046339/doc4.xml","form_type":"4"}},{"id":4250699,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":174218,"kind":"person","name":"Vandervelpen Nico","position":1,"cik":"0001618165","reported_name":"Vandervelpen Nico","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-07-26T21:03:10.000Z","date":"2017-07-24","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on December 4, 2015 and provides for vesting quarterly over 3 years beginning on December 4, 2015."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on December 4, 2015 and provides for vesting quarterly over 3 years beginning on December 4, 2015."}],"balance_after":25000,"derivative":{"exercise_price":4.71,"expiration_date":"2018-07-24","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-17-046339","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919117046339/doc4.xml","form_type":"4"}},{"id":4250698,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":174218,"kind":"person","name":"Vandervelpen Nico","position":1,"cik":"0001618165","reported_name":"Vandervelpen Nico","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-07-26T21:03:10.000Z","date":"2017-07-24","kind":"disposition_to_issuer","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on December 4, 2015 and provides for vesting quarterly over 3 years beginning on December 4, 2015."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option. The option was originally granted on December 4, 2015 and provides for vesting quarterly over 3 years beginning on December 4, 2015."}],"balance_after":0,"derivative":{"exercise_price":4.71,"expiration_date":"2025-12-03","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-17-046339","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919117046339/doc4.xml","form_type":"4"}},{"id":4292251,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":174218,"kind":"person","name":"Vandervelpen Nico","position":1,"cik":"0001618165","reported_name":"Vandervelpen Nico","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-05T20:42:34.000Z","date":"2017-06-01","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 1, 2017 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date."}],"balance_after":12500,"derivative":{"exercise_price":10,"expiration_date":"2027-05-31","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-17-037761","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919117037761/doc4.xml","form_type":"4"}}]}